656 related articles for article (PubMed ID: 26949218)
21. Targeting glutamatergic and cellular prion protein mechanisms of amyloid β-mediated persistent synaptic plasticity disruption: Longitudinal studies.
Zhang D; Qi Y; Klyubin I; Ondrejcak T; Sarell CJ; Cuello AC; Collinge J; Rowan MJ
Neuropharmacology; 2017 Jul; 121():231-246. PubMed ID: 28390893
[TBL] [Abstract][Full Text] [Related]
22. Cellular prion protein as a therapeutic target in Alzheimer's disease.
Laurén J
J Alzheimers Dis; 2014; 38(2):227-44. PubMed ID: 23948943
[TBL] [Abstract][Full Text] [Related]
23. Accumulation of cellular prion protein within β-amyloid oligomer plaques in aged human brains.
Takahashi RH; Yokotsuka M; Tobiume M; Sato Y; Hasegawa H; Nagao T; Gouras GK
Brain Pathol; 2021 Sep; 31(5):e12941. PubMed ID: 33624334
[TBL] [Abstract][Full Text] [Related]
24. Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP.
Wang Z; Jackson RJ; Hong W; Taylor WM; Corbett GT; Moreno A; Liu W; Li S; Frosch MP; Slutsky I; Young-Pearse TL; Spires-Jones TL; Walsh DM
J Neurosci; 2017 Dec; 37(49):11947-11966. PubMed ID: 29101243
[TBL] [Abstract][Full Text] [Related]
25. A d-enantiomeric peptide interferes with heteroassociation of amyloid-β oligomers and prion protein.
Rösener NS; Gremer L; Reinartz E; König A; Brener O; Heise H; Hoyer W; Neudecker P; Willbold D
J Biol Chem; 2018 Oct; 293(41):15748-15764. PubMed ID: 30131337
[TBL] [Abstract][Full Text] [Related]
26. Binding Sites for Amyloid-β Oligomers and Synaptic Toxicity.
Smith LM; Strittmatter SM
Cold Spring Harb Perspect Med; 2017 May; 7(5):. PubMed ID: 27940601
[TBL] [Abstract][Full Text] [Related]
27. Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers.
Townsend M; Cleary JP; Mehta T; Hofmeister J; Lesne S; O'Hare E; Walsh DM; Selkoe DJ
Ann Neurol; 2006 Dec; 60(6):668-76. PubMed ID: 17192927
[TBL] [Abstract][Full Text] [Related]
28. Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies.
Rowan MJ; Klyubin I; Wang Q; Anwyl R
Biochem Soc Trans; 2005 Aug; 33(Pt 4):563-7. PubMed ID: 16042545
[TBL] [Abstract][Full Text] [Related]
29. Bis(propyl)-cognitin Prevents β-amyloid-induced Memory Deficits as Well as Synaptic Formation and Plasticity Impairments via the Activation of PI3-K Pathway.
Jiang L; Huang M; Xu S; Wang Y; An P; Feng C; Chen X; Wei X; Han Y; Wang Q
Mol Neurobiol; 2016 Aug; 53(6):3832-3841. PubMed ID: 26160762
[TBL] [Abstract][Full Text] [Related]
30. The Ca(2+) channel inhibitor 2-APB reverses β-amyloid-induced LTP deficit in hippocampus by blocking BAX and caspase-3 hyperactivation.
Hu WY; He ZY; Yang LJ; Zhang M; Xing D; Xiao ZC
Br J Pharmacol; 2015 May; 172(9):2273-85. PubMed ID: 25521332
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of the Motor Protein Eg5/Kinesin-5 in Amyloid β-Mediated Impairment of Hippocampal Long-Term Potentiation and Dendritic Spine Loss.
Freund RK; Gibson ES; Potter H; Dell'Acqua ML
Mol Pharmacol; 2016 May; 89(5):552-9. PubMed ID: 26957206
[TBL] [Abstract][Full Text] [Related]
32. Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers.
Townsend M; Shankar GM; Mehta T; Walsh DM; Selkoe DJ
J Physiol; 2006 Apr; 572(Pt 2):477-92. PubMed ID: 16469784
[TBL] [Abstract][Full Text] [Related]
33. Rosiglitazone prevents amyloid-β oligomer-induced impairment of synapse formation and plasticity via increasing dendrite and spine mitochondrial number.
Xu S; Liu G; Bao X; Wu J; Li S; Zheng B; Anwyl R; Wang Q
J Alzheimers Dis; 2014; 39(2):239-51. PubMed ID: 24150104
[TBL] [Abstract][Full Text] [Related]
34. Impairment of hippocampal long-term potentiation by Alzheimer amyloid beta-peptides.
Chen QS; Kagan BL; Hirakura Y; Xie CW
J Neurosci Res; 2000 Apr; 60(1):65-72. PubMed ID: 10723069
[TBL] [Abstract][Full Text] [Related]
35. Hippocampal stem cells promotes synaptic resistance to the dysfunctional impact of amyloid beta oligomers via secreted exosomes.
Micci MA; Krishnan B; Bishop E; Zhang WR; Guptarak J; Grant A; Zolochevska O; Tumurbaatar B; Franklin W; Marino C; Widen SG; Luthra A; Kernie SG; Taglialatela G
Mol Neurodegener; 2019 Jun; 14(1):25. PubMed ID: 31200742
[TBL] [Abstract][Full Text] [Related]
36. Serotonin type 6 receptor antagonist attenuates the impairment of long-term potentiation and memory induced by Abeta.
Shahidi S; Hashemi-Firouzi N; Asl SS; Komaki A
Behav Brain Res; 2019 May; 364():205-212. PubMed ID: 30735758
[TBL] [Abstract][Full Text] [Related]
37. Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation.
Walsh DM; Townsend M; Podlisny MB; Shankar GM; Fadeeva JV; El Agnaf O; Hartley DM; Selkoe DJ
J Neurosci; 2005 Mar; 25(10):2455-62. PubMed ID: 15758153
[TBL] [Abstract][Full Text] [Related]
38. Neurotransmitter receptor and time dependence of the synaptic plasticity disrupting actions of Alzheimer's disease Aβ in vivo.
Klyubin I; Ondrejcak T; Hayes J; Cullen WK; Mably AJ; Walsh DM; Rowan MJ
Philos Trans R Soc Lond B Biol Sci; 2014 Jan; 369(1633):20130147. PubMed ID: 24298149
[TBL] [Abstract][Full Text] [Related]
39. Protection against β-amyloid-induced synaptic and memory impairments via altering β-amyloid assembly by bis(heptyl)-cognitin.
Chang L; Cui W; Yang Y; Xu S; Zhou W; Fu H; Hu S; Mak S; Hu J; Wang Q; Ma VP; Choi TC; Ma ED; Tao L; Pang Y; Rowan MJ; Anwyl R; Han Y; Wang Q
Sci Rep; 2015 Jul; 5():10256. PubMed ID: 26194093
[TBL] [Abstract][Full Text] [Related]
40. Alpha4beta2 nicotinic acetylcholine receptors are required for the amyloid beta protein-induced suppression of long-term potentiation in rat hippocampal CA1 region in vivo.
Wu MN; He YX; Guo F; Qi JS
Brain Res Bull; 2008 Sep; 77(2-3):84-90. PubMed ID: 18602971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
